Geriatrics News

Long-term use of antipsychotics is common among older adults in the United States despite safety concerns, according to study results published in Journal of Clinical Psychiatry.

Higher altitude was associated with a lower mortality rate for Alzheimer dementia, according to study findings in JAMA Psychiatry.

Results from a population-based cohort study indicate individuals with schizophrenia, particularly those aged younger than 65 years, had increased relative risk for dementia that was not explained by dementia risk factors.

Analysis of a nationally representative, longitudinal sample of adults aged 50 years and older indicated frequency of in-person social contact with friends and family independently predicted risk for subsequent depression among this population.

The NIH awarded Heng Huang, MS, PhD, a professor in the computer science and engineering department at the University of Texas at Arlington, a 5-year, $2 million grant to assess individuals’ probability of developing Alzheimer’s disease using imaging genomics.

Adding aripiprazole to existing treatment was effective in achieving and sustaining remission for treatment-resistant depression, according to data published in The Lancet.

Study findings in JAMA Neurology indicate no clinically significant effect of avagacestat on cerebrospinal fluid amyloid biomarkers or clinical measures of prodromal Alzheimer’s disease.

Changing mental health treatments for older adults in the United States are due to the aging population, shifting diagnostic criteria and new health care policies, according to an editorial in the Harvard Review of Psychiatry.

A combination of dextromethorphan-quinidine effectively treated agitation among individuals with probable Alzheimer’s disease, according to study results.

Adults with atrial fibrillation had a higher risk for dementia than those without atrial fibrillation, regardless of whether they had experienced a stroke, according to the results of a prospective, population-based study.